L&C BIO Co.,LTD (290650.KQ) has a MoatMap StockRank of 13/100 based on Quality (34/100), Value (21/100), and Momentum (42/100) factor scores. The current signal is STRONG SELL.
L&C BIO Co.,LTD operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C BIO Co.,LTD was founded in 2011 and is headquartered in Seongnam-si, South Korea.
| Price | $54.50 |
| Market Cap | $1.3B |
| P/E (Forward) | 37.52 |
| Price/Book | 10.16 |
| Return on Equity | -53.4% |
| Return on Invested Capital | -70.4% |
| Debt/Equity | 41.03 |
| Gross Margin | 55.0% |
| Operating Margin | 19.8% |
| Revenue Growth | 71.4% |
| Dividend Yield | 0.1% |
| Free Cash Flow | $45K |
L&C BIO Co.,LTD operates in the Medical Devices industry, part of the Healthcare sector (South Korea).